WALTHAM, Mass.--(BUSINESS WIRE)--OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN), a leading developer of biopharmaceutical compounds to treat cancer and certain ophthalmologic diseases, will announce its third quarter 2006 results on Wednesday, October 25, 2006 prior to the opening of the NASDAQ Stock Market, followed by a conference call at 10:00 a.m. ET. OXiGENE’s President and Chief Executive Officer, Richard Chin, MD, Chief Financial Officer, James Murphy, Chief Scientific Officer, David Chaplin, Ph.D. and Chief Medical Officer, Dr. Peter Harris, will host the call.
